Somnomed Ltd has released a press release.
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Somnomed
- Completion of retail component of Entitlement Offer
- Replacement Prospectus
- Reinstatement to Quotation
- Completion of institutional component of Entitlement Offer
- Revised guidance and capital raising
Later from Somnomed
- FY24 Preliminary Report and FY25 Guidance
- Investor Presentation
- Rest Assure - US Food and Drug Authority (FDA) Update
- FY25 Guidance Upgrade and Appointment of CFO
- Investor Presentation AGM
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed